Patients’ barrier to adherence with glaucoma therapy Experience: Qualitative research study.

Main Article Content

Prasanee Pankasikorn

Abstract

Purpose: To explore the experiencing with therapeutic glaucoma adherence in people with glaucoma regarding the obstructive factors and the adherence importance to health outcomes.


Methods: This qualitative study, purposive sampling was used to recruit ten glaucoma patients.  Data were collected at the outpatient ophthalmology clinic at Thammasat University Hospital between January and June 2017 using in-depth interviews along with observation and field records.  Data were analyzed using content analysis.


Results: The main findings illustrated that adherence barriers with glaucoma therapy in people with glaucoma were 1) lacking essential knowledge and 2) forgetfulness.  Also, adherence is crucial to the overall general health of glaucoma patients because it helps them able to proper healthcare, resulting in better therapeutic outcomes, and able to independent living.


Conclusion: The results an understanding of specific obstacles to adherence with anti-glaucomatous therapy.  Future research should focus on investigating methods by which primary education related glaucoma and nursing management should be delivered to patients with glaucoma, leading to preserve the remaining eyesight diminishes.


Conflict of interest: none


Keywords: Barrier to adherence; Experience; Patient with glaucoma; Qualitative research

Keywords

Article Details

Section
Original Study

References

References
1. Quigley HA, Vitale S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci. 1997;38: 83–91.
2. Robin A, Grover DS. Compliance and adherence in glaucoma management. Indian of Ophthalmol. 2011;59(s1): s93-96.
3. Taylor SA, Galbraith SM, Mills RP. Causes of noncompliance with drug regimens in glaucoma patients: a Qualitative study. Journal of ocular pharmacology and therapeutic. 2002; 18(5): 401-409.
4. Konstas AG, Maskaleris G, Gratsonidis S, Sardelli C. Compliance and viewpoint of glaucoma patients in Greece. Eye. 2000;14(Pt 5):752-756.
5. Pong JCF, Lai JSM, Tham CCY, Lam DSC. Compliance with topical antiglaucoma medications. HKJ. Ophthalmol, 2003, 9(1): 12-15.
6. Horne R, Parham R, Driscoll R, Robinson A. Patients’ attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm. Bowel Dis, 2009. 15(6): 837-844.
7. Denis P. Adverse Effect, Adherence and Cost-Benefits in Glaucoma Treatment. European Ophthalmic Review, 2011. 5(2): 116-122.
8. Horne R, Chapman SC, Parham R, Freemantle N, Forbes A. Understanding Patients’ Adherence-related beliefs about medicines prescribed for long-term conditions: A Meta-Analytic review of the necessity-concerns framework, PLoS ONE. (2013).8(12), doi: 10.1371/journal.pone.0080633.
9. Sandelowski M. The problem of rigor in qualitative research. Adv Nurs Sci. 1986;8(3): 27-37.
10. Mayan ML. An introduction to qualitative methods: A training module for students and professionals. Alberta: International Institute for Qualitative methodology; 2001.
11. Dey I. Qualitative data analysis: a user-friendly guide for social scientist. New York: Routledge; 1993.
12. Kosoko O, Quigley HA, Vitale S, Enger C, Kerrigan L, Tielsch JM. Risk factors for noncompliance with glaucoma follow-up visits in a residents’ eye clinic. Ophthalmology 1998;105: 2105-2111.
13. Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW. Compliance barriers in glaucoma: a systematic classification, Journal of Glaucoma. 2003:12(5): 393-398.
14. Robin A, Grover DS. Compliance and adherence in glaucoma management. Indian J Ophthalmol. 2011;59 (Suppl 1): S93-96.
15. Nutheti R, Shamanna BR, Nirmalan PK, Keeffe JE, Krishnaiah S, Rao GN, Thomas R. Impact of impaired vision and eye disease on quality of life in Andhra Pradesh. Investigative ophthalmology & visual science. 2006:47(11): 4742-4748.